Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Berkowitz

Showing results (481-490 of 671) with videos related to

Pageof 68
Sort By:
Journal of the National Cancer Institute|July 1, 1985
Risk factors for fibrocystic breast disease and its histopathologic componentsG S Berkowitz, J L Kelsey, V A LiVolsi, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Diagnosis and management of gestational trophoblastic disease: 2021 updateHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Gynecologic Oncology|September 21, 2017
Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?Patrícia Rangel Sobral Dantas, Izildinha Maestá, Jorge Rezende Filho, et al.
The American Journal of Medicine|October 1, 1973
Ocular complications in renal transplant recipientsJ S Berkowitz, D S David, S Sakai, et al.
The Journal of Reproductive Medicine|September 9, 2008
Vascularization and expression of angiogenic factors in partial and complete molar pregnanciesZoltan Nagymanyoki, Whitfield B Growdon, Jennifer Sarno, et al.
Journal of Medicinal Chemistry|May 1, 1978
Analgesics. 1. Synthesis and analgesic properties of N-sec-alkyl- and N-tert-alkylnormorphinesJ I DeGraw, J A Lawson, J L Crase, et al.
Gynecologic Oncology|August 5, 2014
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinomaMichael J Worley, Michelle Davis, Saba H Berhie, et al.
Pageof 68

Showing results (481-490 of 671) with videos related to

Sort By:
Pageof 68
Journal of the National Cancer Institute|July 1, 1985
Risk factors for fibrocystic breast disease and its histopathologic componentsG S Berkowitz, J L Kelsey, V A LiVolsi, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Diagnosis and management of gestational trophoblastic disease: 2021 updateHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Gynecologic Oncology|September 21, 2017
Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?Patrícia Rangel Sobral Dantas, Izildinha Maestá, Jorge Rezende Filho, et al.
The American Journal of Medicine|October 1, 1973
Ocular complications in renal transplant recipientsJ S Berkowitz, D S David, S Sakai, et al.
The Journal of Reproductive Medicine|September 9, 2008
Vascularization and expression of angiogenic factors in partial and complete molar pregnanciesZoltan Nagymanyoki, Whitfield B Growdon, Jennifer Sarno, et al.
Journal of Medicinal Chemistry|May 1, 1978
Analgesics. 1. Synthesis and analgesic properties of N-sec-alkyl- and N-tert-alkylnormorphinesJ I DeGraw, J A Lawson, J L Crase, et al.
Gynecologic Oncology|August 5, 2014
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinomaMichael J Worley, Michelle Davis, Saba H Berhie, et al.
Pageof 68